Press Releases

 Filter by Provider

MFS Investment Management (“MFS”) announced today that shareholders of MFS Charter Income Trust (NYSE: MCR) and MFS Intermediate High Income Fund (NYSE: CIF) (each a “Target Fund” and collectively, the “Target Funds”) have approved the reorganization of each Target Fund into MFS Multimarket Income Trust (NYSE: MMT) (the “Surviving Fund”) (each a “Reorganization” and collectively, the “Reorganizations”) and that shareholders of the Surviving Fund have approved (i) the appointment of abrdn Inc. (“Aberdeen”) as the new investment adviser, (ii) the appointment of five new trustees, and (iii) the issuance of additional common shares in connection with the Reorganizations. MFS will provide further details concerning the timing for the consummation of each of these initiatives shortly.

Limbach Holdings, Inc. (NASDAQ: LMB) (“Limbach” or the “Company”), a building systems solutions firm that partners with building owners and operators who have mission-critical mechanical, electrical, plumbing and controls, or MEPC, systems, today announced the appointment of Michael Reed to the newly created position of Executive Vice President, Chief Operating Officer, effective May 18, 2026.

InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Company’s Board of Directors has approved a stock repurchase program authorizing the Company to repurchase up to $20 million of the Company’s outstanding common stock starting on July 1, 2026 and running through June 30, 2028. The program will supersede the previous authorization which is set to expire on June 30, 2026. Under the current authorization, the Company repurchased approximately 1.6 million shares of stock for approximately $11.9 million though March 31, 2026. Repurchases will be made through open market purchases, private transactions, or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 under the Securities Exchange Act of 1934 (the “Exchange Act”).

Data reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of recapitulating the protective MZ-like phenotype with monthly dosing 

RESEARCH TRIANGLE PARK, N.C., May 18, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on May 11, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of stock option awards (“Stock Options”) to purchase an aggregate of 50,000 of the Company’s common shares to three new non-executive employees of the Company with a grant date of May 18, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The Stock Options consist of incentive stock options to purchase an aggregate of 49,141 shares and nonqualified stock options to purchase an aggregate of 859 shares. The Stock Options were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

Connecticut's major health systems continue to recruit specialists from out of state, drawing physicians into a housing market that spans Fairfield County's NYC commuter premium to more accessible central Connecticut. Specialty mortgage programs help relocating doctors navigate the financial transition.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hercules Capital (HTGC) To Contact Him Directly To Discuss Their Options

JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) declared a quarterly dividend on the outstanding shares of the common stock of JPMorganChase. Information can be found on the Firm’s Investor Relations website at https://www.jpmorganchase.com/ir/news.

Revelyst Inc., a collective of world-class maker brands that design and manufacture sports technology and outdoor gear, today announced the appointment of Dave Mellon as President of Simms Fishing Products and Revelyst Outdoor Performance, the company’s Bozeman-based platform that includes Simms and several other iconic outdoor brands within the Revelyst portfolio.

Georgia Governor Brian Kemp has approved legislation that broadens access to the state’s medical cannabis program, introducing several changes aimed at expanding treatment options for eligible patients while maintaining restrictions on recreational marijuana. The measure, Senate Bill 220, adds new qualifying medical conditions, revised rules on THC limits, and expanded methods for how patients may use cannabis products.

Georgia Governor Brian Kemp has approved legislation that broadens access to the state’s medical cannabis program, introducing several changes aimed at expanding treatment options for eligible patients while maintaining restrictions on recreational marijuana. The measure, Senate Bill 220, adds new qualifying medical conditions, revised rules on THC limits, and expanded methods for how patients may use cannabis products.

Hamilton Insurance Group, Ltd. (NYSE: HG) (“Hamilton” or the “Company”) today announced the appointment of Christopher (“Chris”) R. Stella as Chief Claims Officer of Hamilton Select, its primary carrier for domestically placed US excess and surplus (“E&S”) business, effective May 18, 2026.

Enhabit, Inc., a leading home health and hospice provider, today announced that Dale Clift has been appointed president and CEO, following the successful completion of the company’s acquisition by Kinderhook Industries.

XP Inc. (Nasdaq: XP), announced, in a planned and mutually agreed succession, a transition in its Chief Financial Officer role as part of the Company’s continued evolution and next phase of growth. Mr. Gustavo Alejo Viviani has been appointed by the Board of Directors of the Company (the “Board”) to serve as the Company’s new Chief Financial Officer, effective August 3, 2026. The Company believes that Mr. Alejo brings the expertise, skillset and experience needed to support XP in its continued growth and the execution of its long-term strategy.

XP Inc. (Nasdaq: XP), announced today that its board of directors has approved two capital allocation actions: (i) the declaration of a cash dividend and (ii) the authorization of a new share repurchase program.

After deploying Helpany's radar-based AI platform in January 2026, United Zion senior living community cut falls by 70% in four months - and closed April with zero recorded falls, a first in the community's history

NEW YORK CITY, NY / ACCESS Newswire / May 18, 2026 / Energy Transition Special Opportunities (the "Company") today announced the completion of its initial public offering of 15,000,000 units at $10.00 per unit, raising $150,000,000 in gross proceeds. The Company's units began trading on the New York Stock Exchange ("NYSE") on May 15, 2026 under the ticker symbol ETSS U. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols "ETSS" and "ETSS WS," respectively.

Penguin Solutions, Inc. (“Penguin Solutions” or the “Company”) (Nasdaq: PENG), the AI Factory Platform company, today announced that David Heard, President of Network Infrastructure at Nokia, has been appointed to Penguin Solutions’ board of directors, effective immediately.

Bally’s Corporation (NYSE: BALY) (“Bally’s” or the “Company”) today reported financial results for the first quarter ended March 31, 2026.

QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (Nasdaq: QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today the closing of its previously announced underwritten public offering of 2,000,000 shares of common stock (or pre-funded warrants in lieu thereof) for gross proceeds of approximately $10 million.

XP Inc. (NASDAQ: XP) (“XP” or the “Company”), a leading tech-enabled platform and a trusted pioneer in providing low-fee financial products and services in Brazil, reported today its financial results for the first quarter of 2026.

ECA MARCELLUS TRUST I (OTCID Basic Market: ECTM) announced today that the Trust’s distribution for the quarter ended March 31, 2026, will be $0.090 per unit, which is expected to be distributed on or before June 2, 2026, to holders of record as of the close of business on May 28, 2026.

Champion Homes, Inc. (“Champion Homes”) today announced the Offsite Construction Event 2026, an exciting gathering of home builders and developers offering an in-depth look at how offsite construction can help them scale their businesses. This high-impact event is free to attend and will be held June 16-17, 2026, in York, Neb.

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the New England Journal of Medicine has published the full results of its TETON-1 study, as well as combined analyses of its TETON-1 and TETON-2 studies, evaluating the use of nebulized Tyvaso for the treatment of IPF. The publication is available here. A summary of the publication was also presented today during a symposium at the annual meeting of the American Thoracic Society (ATS) International Conference in Orlando. The use of nebulized Tyvaso for IPF has not been approved by the U.S. Food and Drug Administration (FDA) and remains investigational for IPF.

Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, today announced the enrollment of the first patient in its first-in-human (FIH) study for Pulsatile Intravascular Lithotripsy (PIVL) therapy in a coronary indication.

Permianville Royalty Trust (NYSE: PVL, the “Trust”) today announced a cash distribution to the holders of its units of beneficial interest of $0.014000 per unit, payable on June 12, 2026, to unitholders of record on May 29, 2026. The net profits interest calculation represents reported oil production for the month of February 2026 and reported natural gas production during January 2026. The calculation includes accrued costs incurred in March 2026.

MFS® Investment Grade Municipal Trust (the “Fund”) (NYSE: CXH) announced today that, in accordance with its tender offer for up to 50% of the Fund’s outstanding common shares (the “Shares”), which expired at 5:00 P.M., Eastern Time, on May 12, 2026, the Fund has accepted 4,099,610 Shares, representing 50% of the Shares, for payment on or about May 18, 2026.

EnerSys (NYSE: ENS), a global leader in stored energy solutions for industrial applications, today announced the launch of the AlphaCell™ 4.0HP+ battery, a Thin Plate Pure Lead (TPPL) battery engineered to improve electrochemical stability and support replacement interval stability in outdoor and edge communications network deployments across North America.

Builders FirstSource, Inc. (NYSE: BLDR) announced today that as part of a planned leadership transition, Mike Hiller has been appointed Chief Operating Officer-Designate, succeeding Steve Herron, who will retire on December 31, 2026.

RADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:

WALTHAM, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced that on May 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted an aggregate of 51,075 restricted stock units of the Company’s common stock (“RSUs”) to newly hired employees of the Company as an inducement material to such employees’ entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).

Flexsteel Industries, Inc. (NASDAQ:FLXS) (“Flexsteel” or the “Company”), one of the largest manufacturers, importers, and marketers of residential furniture products in the United States, today announced that Derek Schmidt, President and Chief Executive Officer, and Mike Ressler, Chief Financial Officer, will present and host one-on-one meetings with investors at Sidoti’s Micro-Cap Virtual Investor Conference taking place on May 21, 2026.

New collaboration brings together advanced payment processing, employee and business membership benefits, and scalable partner programs to help organizations simplify operations, reduce costs, and create new value for their customers and members.

ORLANDO, FL / ACCESS Newswire / May 18, 2026 / RedChip Companies will host an investor webinar on May 20, 2026, at 4:15 p.m. ET with Bimergen Energy Corporation (NYSE American:BESS) ("Bimergen"), a U.S.-based independent power provider specializing in the development, ownership, and operation of standalone battery energy storage systems (BESS).

DENVER, CO / ACCESS Newswire / May 18, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026.

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company presented its latest research at the Oncology Nursing Society (ONS) Congress, May 13-17. The poster at ONS was titled, “Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration.”

CoreWeave, Inc. (Nasdaq: CRWV), The Essential Cloud for AI™, today announced it has closed its $3.1 billion delayed draw term loan facility (“DDTL 5.0 Facility”), supporting continued expansion of its AI cloud platform and committed customer deployments.

Agilysys, Inc. (NASDAQ: AGYS), a leading global provider of hospitality software solutions and services, today reported results for its fiscal 2026 fourth quarter and full year ending March 31, 2026.

Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of test measurement, control and calibration services, announced that it will release its results for the fourth quarter fiscal year 2026 ended March 28, 2026 after the close of financial markets on Tuesday, May 26, 2026.

Mesa Royalty Trust (the “Trust”) (NYSE: MTR) announced today the Trust income distribution for the month of May 2026. Unitholders of record on May 29, 2026 will receive distributions amounting to $0.024505172 per unit, payable on July 31, 2026. The Trust received $54,382, all of which came from the New Mexico portion of the Trust’s San Juan Basin properties operated by Hilcorp San Juan LP, an affiliate of Hilcorp Energy Company. No income was received in May 2026 from any other working interest owner. This month, after payment of administrative expenses, income from the distributable net profits was $45,668.

Sonos, Inc. (Nasdaq: SONO) today announced that Saori Casey, Chief Financial Officer, will participate in a fireside chat with Jefferies analyst Brent Thill at the 2026 Jefferies Software, Internet, and AI Conference on Wednesday, May 27th. The fireside chat will begin at 3:30 pm Pacific. A live webcast and replay of the fireside chat will be accessible in the News & Events section of the Sonos investor relations website: https://investors.sonos.com/news-and-events/default.aspx#section=events-and-presentations.

AXT, Inc. (Nasdaq: AXTI), a leading manufacturer of compound semiconductor substrates, today announced that it will participate in the upcoming financial conferences:

LCNB Corp. (Nasdaq: LCNB) today announced that the Company’s Board of Directors declared a cash dividend of $0.22 per common share. The common stock cash dividend will have a record date of June 1, 2026, and is payable to shareholders on June 15, 2026.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will present data from the Phase 2 SOLSTICE trial evaluating the combination of tobevibart and elebsiran for chronic hepatitis delta at the upcoming EASL Congress 2026 in Barcelona, Spain, May 27-30, 2026.

Rocky Brands, Inc. (NASDAQ: RCKY) today announced that its board of directors has declared a quarterly cash dividend of $0.17 per share of outstanding common stock, which will be paid on June 15, 2026, to all shareholders of record as of the close of business on June 1, 2026.

LATHAM, N.Y., May 18, 2026 (GLOBE NEWSWIRE) -- Latham Group, Inc. (NASDAQ:SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that management will attend the following investor conferences:

BURLINGTON, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will participate in the 2026 Jefferies Global Healthcare Conference being held June 2-4, 2026 in New York, NY.

JERSEY CITY, N.J., May 18, 2026 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT; SGX: AVP), the global leader in AI data protection, unifying data security, governance, and resilience, today announced that members of the Company’s executive management team will present at the following investor conferences: 

Event to be Webcast Live on the MediaAlpha Investor Relations Website

BRISBANE, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to three new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on May 11, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).